BioStem Technologies, Inc. (BSEM)
BioStem Technologies Market Cap : 84.47M for Sept. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 84.47M |
| September 17, 2026 | 77.70M |
| September 16, 2026 | 72.71M |
| September 15, 2026 | 71.46M |
| September 14, 2026 | 75.03M |
| September 11, 2026 | 76.81M |
| September 10, 2026 | 74.40M |
| September 09, 2026 | 75.03M |
| September 08, 2026 | 71.29M |
| September 04, 2026 | 66.12M |
| September 03, 2026 | 64.34M |
| September 02, 2026 | 63.09M |
| September 01, 2026 | 62.38M |
| August 31, 2026 | 65.58M |
| August 28, 2026 | 62.91M |
| August 27, 2026 | 68.61M |
| August 26, 2026 | 65.23M |
| August 25, 2026 | 67.90M |
| August 24, 2026 | 69.86M |
| August 21, 2026 | 63.09M |
| August 20, 2026 | 65.58M |
| August 19, 2026 | 59.61M |
| August 18, 2026 | 56.14M |
| August 17, 2026 | 53.46M |
| August 14, 2026 | 57.21M |
| Date | Value |
|---|---|
| August 13, 2026 | 55.25M |
| August 12, 2026 | 67.72M |
| August 11, 2026 | 64.34M |
| August 10, 2026 | 67.37M |
| August 07, 2026 | 69.44M |
| August 06, 2026 | 68.20M |
| August 05, 2026 | 56.56M |
| August 04, 2026 | 55.28M |
| August 03, 2026 | 52.93M |
| July 31, 2026 | 56.23M |
| July 30, 2026 | 54.45M |
| July 29, 2026 | 55.82M |
| July 28, 2026 | 56.85M |
| July 27, 2026 | 64.81M |
| July 24, 2026 | 68.03M |
| July 23, 2026 | 65.05M |
| July 22, 2026 | 66.68M |
| July 21, 2026 | 67.53M |
| July 20, 2026 | 66.00M |
| July 17, 2026 | 63.96M |
| July 16, 2026 | 63.61M |
| July 15, 2026 | 64.62M |
| July 14, 2026 | 64.47M |
| July 13, 2026 | 67.12M |
| July 10, 2026 | 62.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Filana Therapeutics, Inc. | 35.07M |
| CorMedix, Inc. | 599.59M |
| Eloxx Pharmaceuticals, Inc. | 70.44M |
| Breakthrough Chemistry, Inc. | 0.6888M |
| Cardiac Biotech Solutions, Inc. | 6.204M |
Market Cap Related Metrics
| PS Ratio | 2.543 |
| Price to Book Value | 3.059 |
| Price | 4.74 |
| Earnings Yield | -35.41% |